Alberto (@drarzola) 's Twitter Profile
Alberto

@drarzola

Neumólogo
Unidad de Cuidados Intensivos Respiratorios
Orgulloso CMN La Raza

ID: 352716825

calendar_today11-08-2011 00:33:43

51,51K Tweet

1,1K Followers

1,1K Following

Respiratory Therapy Zone (@respiratoryzone) 's Twitter Profile Photo

Pneumonia is an infection of the lung parenchyma that causes inflammation and fluid-filled alveoli, leading to impaired gas exchange and oxygenation. respiratorytherapyzone.com/pneumonia/?utm…

Pneumonia is an infection of the lung parenchyma that causes inflammation and fluid-filled alveoli, leading to impaired gas exchange and oxygenation. respiratorytherapyzone.com/pneumonia/?utm…
CHEST (@accpchest) 's Twitter Profile Photo

A new CHEST guideline offers recommendations to optimize the use of biologic agents in patients with severe asthma. Read the full guideline: hubs.la/Q04cGbSG0 #CritCare #SevereAsthma

A new CHEST guideline offers recommendations to optimize the use of biologic agents in patients with severe asthma. 
Read the full guideline: hubs.la/Q04cGbSG0

#CritCare #SevereAsthma
CHEST (@accpchest) 's Twitter Profile Photo

Biomarkers are important to describe inflammatory and molecular endotypes that pave the way for individualized therapeutic targets. This infographic from the CHEST Airways Disorders Network outlines biomarkers in bronchiectasis. Learn more: hubs.la/Q04drF8W0

Biomarkers are important to describe inflammatory and molecular endotypes that pave the way for individualized therapeutic targets. This infographic from the CHEST Airways Disorders Network outlines biomarkers in bronchiectasis. 

Learn more: hubs.la/Q04drF8W0
Abraham Alí Munive (@abrahamalimd) 's Twitter Profile Photo

¿Por qué dejamos morir de asma a pacientes con GOLD-1 COPD? GOLD-1: FEV1 ≥80% predicted. La guía lo llama "mild". Los pacientes sintomáticos declinen 39 ml/año (SPIROMICS II) y progresan a GOLD 2-4 en 1 de cada 5 casos (COPDGene). Pero seguimos esperando a que se enfermen más.

¿Por qué dejamos morir de asma a pacientes con GOLD-1 COPD?

GOLD-1: FEV1 ≥80% predicted. La guía lo llama "mild". Los pacientes sintomáticos declinen 39 ml/año (SPIROMICS II) y progresan a GOLD 2-4 en 1 de cada 5 casos (COPDGene). Pero seguimos esperando a que se enfermen más.
𝗦𝗮𝗹𝗲𝗲𝗺 𝗡. 𝗛𝗮𝗺𝗶𝗹𝗮𝗵 🫁| ســليم هميــله (@saleemhamilah) 's Twitter Profile Photo

🤯🔶️ Surgical emphysema / subcutaneous emphysema! ✅️Surgical emphysema means air trapped under the skin, usually in the chest, neck, face, or around a surgical/trauma site. It feels like crackling/crepitus when touched. #subcutaneousemphysema #pneumothorax

🤯🔶️ Surgical emphysema / subcutaneous emphysema!

✅️Surgical emphysema means air trapped under the skin, usually in the chest, neck, face, or around a surgical/trauma site. It feels like crackling/crepitus when touched.

 #subcutaneousemphysema #pneumothorax
Abraham Alí Munive (@abrahamalimd) 's Twitter Profile Photo

¿Cuántos ciclos cortos de prednisolona puede acumular un paciente con asma o rinosinusitis antes de que el riesgo deje de ser teórico? Meta-análisis EAACI 2026 (37 estudios) responde con un umbral concreto: 0,5–1 g acumulados de prednisolona-equivalente — equivalente a 2–5

¿Cuántos ciclos cortos de prednisolona puede acumular un paciente con asma o rinosinusitis antes de que el riesgo deje de ser teórico?

Meta-análisis EAACI 2026 (37 estudios) responde con un umbral concreto: 0,5–1 g acumulados de prednisolona-equivalente — equivalente a 2–5
Critical Care Reviews (@critcarereviews) 's Twitter Profile Photo

Today's Paper of the Day is: Tuberculosis: An Update for the Clinician criticalcarereviews.com/latest-evidenc… Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2026

Today's Paper of the Day is:

Tuberculosis: An Update for the Clinician

criticalcarereviews.com/latest-evidenc…

Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2026
Critical Care Reviews (@critcarereviews) 's Twitter Profile Photo

Today's Paper of the Day is: Tuberculosis: An Update for the Clinician Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2026 Link in bio

Today's Paper of the Day is:

Tuberculosis: An Update for the Clinician

Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2026

Link in bio
IF8,7 D1 - Arch. Bronconeumología (@archbronconeumo) 's Twitter Profile Photo

😴 Apnea central del sueño en la insuficiencia cardíaca: ¿Y ahora qué? Descubre el análisis en la editorial de #ArchivosdeBronconeumología, firmada por: ✍️ Shahrokh Javaheri ✍️ Winfried J. Randerath ✍️ Alberto Giannoni 🔗 n9.cl/1foe6 #SEPAR #SaludRespiratoria

Sociedad de Medicina de Emergencias de la Laguna (@somelaguna) 's Twitter Profile Photo

🫁☠️Abordaje y Manejo de la Neumonía Necrotizante 🔰📚Pathogens doi.org/10.3390/pathog… Enlace a Artículo Completo👇🏻🆓✅ t.me/SoMELaguna

🫁☠️Abordaje y Manejo de la Neumonía Necrotizante

🔰📚Pathogens

doi.org/10.3390/pathog…

Enlace a Artículo Completo👇🏻🆓✅
t.me/SoMELaguna
IF8,7 D1 - Arch. Bronconeumología (@archbronconeumo) 's Twitter Profile Photo

Want to learn more about the validation of the RISA-PE risk classification in patients with acute pulmonary embolism receiving medical treatment? 🧐 Access the multicenter study featured in the scientific letter of #ArchivosdeBronconeumología ➡️n9.cl/6ebui #SEPAR

Want to learn more about the validation of the RISA-PE risk classification in patients with acute pulmonary embolism receiving medical treatment? 🧐

Access the multicenter study featured in the scientific letter of #ArchivosdeBronconeumología

➡️n9.cl/6ebui

#SEPAR
Enrique Santas (@santasenrique) 's Twitter Profile Photo

🔬 How to best assess congestion in #HeartFailure? Prof Julio Hospital Clínic de València INCLIVA at #HeartFailure26 European Society of Cardiology Multimarker approach: • NT-proBNP 🫀 (intravascular, wall stress) • CA125 🩸 (extravascular, serosal inflammation) • Bio-ADM 🛡️ (vascular barrier,

🔬 How to best assess congestion in #HeartFailure? Prof <a href="/yulnunezvill/">Julio</a> <a href="/GVAclinic/">Hospital Clínic de València</a> <a href="/incliva_iis/">INCLIVA</a> at #HeartFailure26 <a href="/escardio/">European Society of Cardiology</a> 

Multimarker approach:
• NT-proBNP 🫀 (intravascular, wall stress)
• CA125 🩸 (extravascular, serosal inflammation)
• Bio-ADM 🛡️ (vascular barrier,
Heart_BMJ (@heart_bmj) 's Twitter Profile Photo

Identification and management of non-obstructive high-risk coronary artery plaque Please read the article and enjoy an in-depth interview between James Rudd and the first author, University of Edinburgh's Dr Craig Balmforth Publication - bit.ly/4dHJwJd Podcast -

Identification and management of non-obstructive high-risk coronary artery plaque

Please read the article and enjoy an in-depth interview between <a href="/jhfrudd/">James Rudd</a> and the first author, University of Edinburgh's Dr Craig Balmforth

Publication - bit.ly/4dHJwJd

Podcast -
Critical Care Reviews (@critcarereviews) 's Twitter Profile Photo

The Association Between Mechanical Power and Postoperative Pulmonary Complications: A Critical Narrative Review of Clinical Controversies CCR Journal Watch criticalcarereviews.com/latest-evidenc…

The Association Between Mechanical Power and Postoperative Pulmonary Complications: A Critical Narrative Review of Clinical Controversies

CCR Journal Watch
criticalcarereviews.com/latest-evidenc…
Sociedad de Medicina de Emergencias de la Laguna (@somelaguna) 's Twitter Profile Photo

🫁💧Tubo Torácico y Drenaje Pleural - Historia y Situación Actual 🔰📚J. Clin. Med. 2024 doi.org/10.3390/jcm132… Enlace a Artículo Completo👇🏻✅🆓 t.me/SoMELaguna

🫁💧Tubo Torácico y Drenaje Pleural - Historia y Situación Actual 

🔰📚J. Clin. Med. 2024

doi.org/10.3390/jcm132…

Enlace a Artículo Completo👇🏻✅🆓
t.me/SoMELaguna
Abraham Alí Munive (@abrahamalimd) 's Twitter Profile Photo

¿Por qué dos pacientes con la misma exacerbación severa de EPOC tienen pronósticos opuestos? El consorcio CICERO propone el modelo BAt en Lancet Respir Med 2026: estratificación multidimensional con tres dominios usando datos clínicos rutinarios. B (baseline): mMRC + IMC + FEV1

¿Por qué dos pacientes con la misma exacerbación severa de EPOC tienen pronósticos opuestos?

El consorcio CICERO propone el modelo BAt en Lancet Respir Med 2026: estratificación multidimensional con tres dominios usando datos clínicos rutinarios.

B (baseline): mMRC + IMC + FEV1